Screener
Eikon Therapeutics, Inc. EIKN Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q1 '25 | ||
|---|---|---|---|---|
| $161.15M-21.2% | $104.9M— | $204.58M— | ||
| $351.03M— | $231.07M— | —— | ||
| $529.5M— | $348.92M— | —— | ||
| $138.07M— | $142.9M— | —— | ||
| $850.83M— | $594.73M— | —— | ||
| $6.01M+164% | $681K— | $2.28M— | ||
| $45.06M— | $55.01M— | —— | ||
| $300.16M— | $312.3M— | —— | ||
| -$1B— | -$920.51M— | —— | ||
| $550.67M+186% | -$879.03M-53.7% | -$640.14M— | ||
| $850.83M— | $594.73M— | —— |
FAQ
- What are Eikon Therapeutics, Inc.'s total assets?
- Eikon Therapeutics, Inc. (EIKN) holds $850.8M in total assets.
- How much debt does Eikon Therapeutics, Inc. have?
- Eikon Therapeutics, Inc. carries $254.8M in total debt against $550.7M of shareholders' equity, a debt-to-equity ratio of 0.46.
- How much cash does Eikon Therapeutics, Inc. have?
- Eikon Therapeutics, Inc. holds $161.2M in cash and equivalents.
- Can Eikon Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 11.75 — current assets exceed current liabilities.
- Where does Eikon Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Eikon Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.